Community Healthcare Trust CHCT Reclassification of registration statement costs to equity issuance costs
Reclassification of registration statement costs to equity issuance costs at other companies
Other financials
Where this comes from
Reported directly by Community Healthcare Trust in its filing.
Tagged under the XBRL concept chct:ReclassificationOfRegistrationStatementCostsIncurredToEquityIssuanceCosts.
The official record: Community Healthcare Trust’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Community Healthcare Trust's reclassification of registration statement costs to equity issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Community Healthcare Trust's reclassification of registration statement costs to equity issuance costs?
- Community Healthcare Trust (CHCT) reported reclassification of registration statement costs to equity issuance costs of $43K in Q1 2026.
- How has Community Healthcare Trust's reclassification of registration statement costs to equity issuance costs changed year-over-year?
- Community Healthcare Trust's reclassification of registration statement costs to equity issuance costs increased by 13.2% year-over-year, from $38K to $43K.
- What is the long-term trend for Community Healthcare Trust's reclassification of registration statement costs to equity issuance costs?
- Over 2 years (2023 to 2025), Community Healthcare Trust's reclassification of registration statement costs to equity issuance costs has grown at a -5.7% compound annual growth rate (CAGR), from $197K to $175K.
- What does reclassification of registration statement costs to equity issuance costs mean?
- This metric tracks the accounting adjustment where costs previously recorded as registration statement expenses are reclassified as equity issuance costs. This shift typically occurs when a planned offering moves from a registration phase to an active capital raise. It provides transparency into how the company categorizes and capitalizes costs associated with regulatory compliance and equity financing.